GLSI-100 Granted Fast Track Designation for HER2-Positive Breast Cancer
GLSI-100 shows promise in preventing HER2-positive breast cancer recurrence after standard therapy.
Switching from Humira to Biosimilar Did Not Affect Disease Control, Quality of Life in IBD
Patients with inflammatory bowel disease (IBD) who switched to the biosimilar reported adverse events, but these are believed to stem…
1060: Aiming for high-normal potassium to reduce VTach in patients with an ICD
Show notes at pharmacyjoe.com/episode1060. In this episode, I’ll discuss aiming for high-normal potassium to reduce sustained ventricular tachycardia in patients…
Artificial Intelligence: Coming for Your Job or Improving Your Performance?
Don’t be asleep at the wheel. AI is coming, and it’s coming fast.
Measles Outbreak Update, Florida Surgeon General Announces Plan to Remove Vaccine Mandates in Schools
Florida’s Surgeon General’s plan to eliminate school vaccine mandates raises concerns about measles outbreaks and declining vaccination rates.
FDA Expands Selumetinib to Children With NF1-Associated Plexiform Neurofibromas
Selumetinib gains expanded FDA approval for younger pediatric patients with neurofibromatosis type 1 plexiform neurofibromas, enhancing treatment options and addressing…
Gemcitabine Intravesical System Receives FDA Approval for Non–Muscle Invasive Bladder Cancer
The FDA approves a groundbreaking gemcitabine system, offering new hope for patients with BCG-unresponsive bladder cancer.
Study: Women With PCOS at Increased Risk of Acute Myocardial Infarction and Ischemic Stroke
Investigators emphasize that early cardiovascular risk assessments and preventative strategies are necessary for women with polycystic ovarian syndrome (PCOS).
HHS Report Expected to Link Prenatal Tylenol Use and Autism Risk
HHS and Robert F. Kennedy Jr. prepare to unveil a report linking Tylenol use in pregnancy to autism, raising critical…